The Australian: ASX Health Quarterly Wrap – Progress on multiple fronts in strong start to FY26

Stockhead and The Australian included Racura Oncology in an ASX healthcare company quarterly results season wrap up, which highlights ongoing progress, including new discoveries and clinical trial updates to propel growth in FY26.

The article covers Racura’s progress on clinical trials and the company’s discovery of a new way of patenting active chemical form of bisantrene.

Read the full article here.